In Vitro Transdifferentiation of Human Fetal Type II Cells Toward a Type I–like Cell

被引:0
|
作者
Cherie D Foster
Linda S Varghese
Rachel B Skalina
Linda W Gonzales
Susan H Guttentag
机构
[1] University of Pennsylvania School of Medicine,Department of Pediatrics
[2] The Children's Hospital of Philadelphia,undefined
来源
Pediatric Research | 2007年 / 61卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
For alveolar type I cells, phenotype plasticity and physiology other than gas exchange await further clarification due to in vitro study difficulties in isolating and maintaining type I cells in primary culture. Using an established in vitro model of human fetal type II cells, in which the type II phenotype is induced and maintained by adding hormones, we assessed for transdifferentiation in culture toward a type I-like cell with hormone removal for up to 144 h, followed by electron microscopy, permeability studies, and RNA and protein analysis. Hormone withdrawal resulted in diminished type II cell characteristics, including decreased microvilli, lamellar bodies, and type II cell marker RNA and protein. There was a simultaneous increase in type I characteristics, including increased epithelial cell barrier function indicative of a tight monolayer and increased type I cell marker RNA and protein. Our results indicate that hormone removal from cultured human fetal type II cells results in transdifferentiation toward a type I-like cell. This model will be useful for continued in vitro studies of human fetal alveolar epithelial cell differentiation and phenotype plasticity.
引用
收藏
页码:404 / 409
页数:5
相关论文
共 50 条
  • [1] In vitro transdifferentiation of human fetal type II cells toward a type I-like cell
    Foster, Cherie D.
    Varghese, Linda S.
    Skalina, Rachel B.
    Gonzales, Linda W.
    Guttentag, Susan H.
    PEDIATRIC RESEARCH, 2007, 61 (04) : 404 - 409
  • [2] Alveolar type 1 cell marker expression in an in vitro model of human alveolar type I cell transdifferentiation
    Foster, CD
    Varghese, L
    Guttentag, SH
    PEDIATRIC RESEARCH, 2004, 55 (04) : 88A - 88A
  • [3] Density and substrata are important in lung type II cell transdifferentiation in vitro
    Reynolds, LJ
    McElroy, M
    Richards, RJ
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (09): : 951 - 960
  • [4] In vitro model for human fetal lung Type II cell maturation.
    Gonzales, LW
    Angampalli, S
    Beers, MF
    Guttentag, SH
    Ning, Y
    Ballard, PL
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (02) : 212A - 212A
  • [5] Human mast cells decrease SLPI levels in type II – like alveolar cell model, in vitro
    Camilla Hollander
    Max Nyström
    Sabina Janciauskiene
    Ulla Westin
    Cancer Cell International, 3
  • [6] Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro
    Hollander, Camilla
    Nystrom, Max
    Janciauskiene, Sabina
    Westin, Ulla
    CANCER CELL INTERNATIONAL, 2003, 3 (1)
  • [7] SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells
    Mossel, Eric C.
    Wang, Jieru
    Jeffers, Scott
    Edeen, Karen E.
    Wang, Shuanglin
    Cosgrove, Gregory P.
    Funk, C. Joel
    Manzer, Rizwan
    Miura, Tanya A.
    Pearson, Leonard D.
    Holmes, Kathryn V.
    Mason, Robert J.
    VIROLOGY, 2008, 372 (01) : 127 - 135
  • [8] Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation
    Chen, Yao
    Legan, Susan K.
    Mahan, Anne
    Thornton, Janet
    Xu, Haiming
    Schwarz, Margaret A.
    RESPIRATORY RESEARCH, 2012, 13
  • [9] Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation
    Yao Chen
    Susan K Legan
    Anne Mahan
    Janet Thornton
    Haiming Xu
    Margaret A Schwarz
    Respiratory Research, 13
  • [10] Hyperoxia inhibits alveolar epithelial repair by inhibiting the transdifferentiation of alveolar epithelial type II cells into type I cells
    S McKechnie
    D Harrison
    M McElroy
    Critical Care, 12 (Suppl 2):